Related Experiment Video

Updated: Jun 12, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates

Ikhlas S Ahmed1, Hannah J Rohe, Katherine E Twist

  • 1Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536, USA.

The Journal of Biological Chemistry
|June 12, 2010
PubMed

Insights

Progesterone receptor membrane component 1 (Pgrmc1) protein binds epidermal growth factor receptor (EGFR), increasing its levels and promoting cancer growth. Inhibiting Pgrmc1 destabilizes EGFR, offering a potential cancer therapy.

Area of Science:

  • Molecular oncology
  • Cell signaling
  • Cancer biology

Background:

  • Tumorigenesis involves pathways stimulating proliferation and metabolism.
  • Epidermal growth factor receptor (EGFR) is a key driver of cancer progression.
  • Progesterone receptor membrane component 1 (Pgrmc1) is upregulated in tumors and promotes cancer growth.

Purpose of the Study:

  • To investigate the role of Pgrmc1 in regulating EGFR levels and function.
  • To explore the therapeutic potential of targeting the Pgrmc1-EGFR interaction.

Main Methods:

  • Co-precipitation assays to assess Pgrmc1-EGFR binding.
  • Confocal microscopy to determine co-localization.
  • Fractionation studies to analyze subcellular localization.
  • Treatment with Pgrmc1 ligands and EGFR inhibitors.

Main Results:

  • Pgrmc1 increases susceptibility to EGFR inhibitors (AG-1478, erlotinib).
  • Pgrmc1 enhances plasma membrane EGFR levels and co-localizes with EGFR in vesicles.
  • A Pgrmc1 ligand destabilizes EGFR in cancer cell lines, inhibiting growth.

Conclusions:

  • Pgrmc1 binds EGFR, stabilizing its plasma membrane pool and promoting cancer phenotypes.
  • Targeting Pgrmc1 represents a potential therapeutic strategy for EGFR-driven cancers.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.